OBI announced the first study of its Steriwave technology in intensive care (ICU). The study is being undertaken as a collaboration with the Royal Columbian Hospital (RCH) Foundation's Advancing Innovation in Medicine (AIM) division. The study will undergo an initial feasibility phase and pending successful outcomes, the data generated will inform a larger multicentre study involving up to 2,000 ICU patients, investigating Steriwave’s impact on infection prevention and patient outcomes in critic ....
